Reliever versus preventer inhalers: the role matters more than the colour

Reliever vs Preventer Inhalers: Why the Role Matters More Than Colour

A reliever inhaler is used according to an asthma action plan to ease symptoms quickly; a preventer delivers anti-inflammatory treatment intended to reduce symptoms and attacks over time. Some modern combination inhalers can serve both roles, so “blue means reliever” and “brown means preventer” are no longer dependable rules. Check the ingredients and written plan.

Key takeaways

  • Identify an inhaler by its active ingredients and prescribed role, not its casing colour or brand alone.
  • A traditional short-acting reliever opens narrowed airways but does not treat the underlying airway inflammation on its own.
  • Some inhaled-corticosteroid and formoterol combinations are prescribed for both maintenance and symptom relief; not every combination inhaler can be used this way.

What does a reliever inhaler do?

A reliever is intended to provide quick relief when asthma symptoms such as wheeze, chest tightness, cough or breathlessness occur. Traditional relievers include short-acting beta2 agonists such as salbutamol, which relax airway muscle. Their effect on tightening does not replace anti-inflammatory treatment for asthma.

The word “reliever” now covers more than one medicine pattern. The 2025 Global Initiative for Asthma strategy includes short-acting bronchodilators and anti-inflammatory relievers containing an inhaled corticosteroid with a rapid-acting bronchodilator. This is why the active ingredients and action plan are more reliable than a familiar colour.

What does a preventer inhaler do?

A preventer, also called controller or maintenance treatment, is intended to control airway inflammation and reduce future symptoms and exacerbations when used as prescribed. Many contain an inhaled corticosteroid such as budesonide, beclometasone or fluticasone. Some combine a corticosteroid with a long-acting bronchodilator.

Preventers are not judged by whether an immediate sensation is noticeable. This creates a common problem: a quick-acting inhaler feels useful at the moment, while the less noticeable maintenance treatment may be undervalued. In April 2025, the UK medicines regulator warned about over-reliance on blue inhalers because increasing use can mask worsening asthma and is associated with severe attacks.

Can one inhaler be both reliever and preventer?

Yes, when a specific inhaled-corticosteroid combination has been prescribed in an appropriate regimen. In anti-inflammatory reliever (AIR) treatment, an eligible combination is used for symptom relief. In maintenance-and-reliever therapy (MART), the same eligible inhaler has a regular maintenance role and an as-needed reliever role.

Prescribed roleGeneral purposeImportant limitation
Short-acting relieverRapid symptom reliefDoes not supply maintenance anti-inflammatory treatment by itself
Separate preventerOngoing anti-inflammatory controlIs not automatically the inhaler for an acute attack
AIRAnti-inflammatory medicine with each symptom-relief useOnly specified ingredient/device combinations are suitable
MARTOne eligible combination used for maintenance and reliefMust follow the individual’s prescribed plan and maximum-use instructions

The rapid-acting bronchodilator in commonly used AIR or MART combinations is formoterol, paired with an inhaled corticosteroid. A combination containing a different long-acting bronchodilator is not automatically suitable for relief. Using the wrong inhaler during worsening symptoms can delay effective treatment.

Why is inhaler colour an unsafe shortcut?

Colours vary by brand, manufacturer, device and market. Purple, red, pink or grey devices may contain combination treatment, but colour does not state whether the device is prescribed as maintenance only or as maintenance and reliever. Forum questions often show people trying to identify an unfamiliar inhaler from “blue”, “brown” or “pink” alone. That signal is useful: the label needs to answer what colour cannot.

Read the active ingredients, strength, device name and pharmacy label. Keep a current written asthma action plan that identifies which inhaler has which role. Device technique also matters: a metered-dose inhaler, dry-powder inhaler and breath-actuated device require different actions. Singapore’s HealthHub metered-dose inhaler guide explains why poor coordination can reduce delivery to the lungs.

What changes the answer?

  • The diagnosis. Asthma and chronic obstructive pulmonary disease can use some of the same ingredients in different treatment plans.
  • Age and device ability. Young children and people who cannot coordinate a device may need a spacer, mask or different inhaler type.
  • The exact ingredients. Only certain corticosteroid/rapid-bronchodilator combinations have an AIR or MART role.
  • Pregnancy and other conditions. Asthma control remains important, but medicine decisions require individual review.
  • Symptom pattern and recent use. Night waking, activity limitation, repeated reliever use or attacks can signal inadequate control or poor technique.
  • Technique and adherence. A suitable medicine may deliver little to the lungs if the device is used incorrectly.

When is breathing trouble urgent?

Follow the emergency steps in the person’s asthma action plan. Seek urgent medical help if breathing is rapidly worsening, the prescribed reliever is not helping as expected, speaking or walking is difficult because of breathlessness, the person is becoming exhausted or drowsy, or the lips or face look blue or grey. Do not wait for an inhaler to run out before asking for help when symptoms remain severe.

If reliever use is increasing, symptoms are waking you, or the roles of two devices are unclear, arrange an asthma review. Bring every inhaler and spacer so a clinician or pharmacist can identify the ingredients, check technique and update the written plan. Do not borrow another person’s inhaler or reassign a maintenance inhaler as a reliever from its colour or online advice.

Sources